Dr Danilov on Using MRD Status to Predict Outcomes in Hemato

Alexey Danilov, MD, PhD, discusses the use of minimal residual disease to predict outcomes in patients with follicular lymphoma.

Related Keywords

Alexey Danilov , Toni Stephenson Lymphoma Center , Department Of Hematology Hematopoietic Cell Transplantation , Division Of Leukemia , Hematopoietic Cell Transplantation , Onclive Tv , Hematologic Oncology , Mantle Cell Lymphoma ,